Overview of the 81<sup>st</sup> Annual Scientific Meeting of the Japanese Circulation Society　― Cardiovascular Medicine for the Next Generation ―-Reference-Cited by-同舟云学术

Overview of the 81^st Annual Scientific Meeting of the Japanese Circulation Society　― Cardiovascular Medicine for the Next Generation ―

Published:2017 Issue:9 Volume:81 Page:1261-1267
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Fujino Noboru¹,Yoshimuta Tsuyoshi¹,Ichida Fukiko²,Kinugawa Koichiro³,Usuda Kazuo⁴,Kitayama Michihiko⁵,Ino Hidekazu⁶,Kawashiri Masa-aki¹,Tada Hiroshi⁷,Mizuno Sumio⁸,Hayashi Kenshi¹,Takemura Hirofumi⁹,Yamagishi Masakazu¹,

Affiliation:

1. Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine

2. Department of Pediatrics, Faculty of Medicine, University of Toyama

3. Internal Medicine II, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

4. Division of Cardiology, Toyama Prefectural Central Hospital

5. Department of Cardiology, Kanazawa Medical University

6. Department of Internal Medicine, Komatsu Municipal Hospital

7. Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui

8. Department of Cardiology, Fukui Cardiovascular Center

9. Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/81/9/81_CJ-17-0706/_pdf

Reference18 articles.

1. 1. Kawashiri MA, Sakata K, Hayashi K, Gamou T, Kanaya H, Miwa K, et al. Impact of combined lipid lowering and blood pressure control on coronary plaque: Myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study. Heart Vessels 2017; 32: 539–548.

2. 2. Gamou T, Sakata K, Tada H, Konno T, Hayashi K, Ino H, et al. Effect of reverse vessel remodeling on regression of coronary atherosclerosis in patients treated with aggressive lipid- and blood pressure-lowering therapy: Insight from MILLION Study. Circ J, doi:10.1253/circj.CJ-16-1253.

3. 3. Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, et al. The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: Findings from the HCMNet Study. JAMA Cardiol 2017; 2: 419–428.

4. 4. Saleheen D, Natarajan P, Armean IM, Zhao W, Rasheed A, Khetarpal SA, et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature 2017; 544: 235–239.

5. 5. Tada H, Melander O, Louie JZ, Catanese JJ, Rowland CM, Devlin JJ, et al. Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history. Eur Heart J 2016; 37: 561–567.